Why the study?
What is the optimal pharmacological management for obesity-related hypertension?
Population
Obese hypertensive patients
Design
Review
Authors
Loading...
Absence of mortality data precludes evidence-based antihypertensive selection in obesity-related hypertension; leaves optimal management open for dedicated trials.
What is the optimal pharmacological management for obesity-related hypertension?
This review highlights the lack of specific evidence for pharmacological management of obesity-related hypertension and discusses theoretical approaches to treatment.
Sharma et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: